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Professor Farringer: Thanks to everyone for coming. Thanks to 
Aubrey Beckham and Taylor Wilkins and Grace Ann for putting all 
of this together and for all their hard work. And for the whole team 
that came together pretty quickly. Actually, you know we just 
formed the journal and had all the student involvement at the very 
beginning of this first semester of the year. So to throw all this 
together and pull it all out has been amazing, so thanks so much to 
the students.
 I am really excited to be able to introduce our panelists here 
for Industry Perspectives. And, its been really funny in trying to craft 
questions to think through what to ask these folks. It seems like it 
changes day to day with everything that is happening because it is 
such a moving target right now, in terms of where things are going 
and what we can expect. So a lot of what we are going to talk about 
today probably is just “what are some of the various things that have 
been thrown out there that might be changing the landscape of 
healthcare and what can practitioners think about?” “What do we 
need to consider?” And hopefully can just have some good 
conversation about various policy proposals and pieces and parts of 
health care reform.  
 So I am going to introduce our panelists. First, to my right 
here, is Michael Regier. He is general counsel and secretary for 
Vanderbilt University Medical Center in Nashville, Tennessee. He 
received his bachelor’s degree in business administration with 
highest distinction from the University of Kansas and his Juris 
Doctorate from the University of Virginia School of Law, where he 
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was a Dillard Fellow. He became General Counsel and Secretary of 
VMC on April 30th, 2016. He is responsible for all legal and 
regulatory matters as well as risk management and insurance, as 
well as the compliance program, which I am sure is a huge, huge 
job, so he has been busy. Before joining VUMC he had served since 
August 2012 as Vice President and Chief Legal Officer of Atlantic 
Health Systems in Morristown, New Jersey. Which I believe is a 
four-hospital – five hospital health system in New Jersey. And 
before there he served since June of 2007 as Senior Vice President 
of Legal Affairs and General Counsel and Secretary of VHA, now 
Visiant, in Irving, Texas. While at VHA he had responsibilities in 
legal, risk management, office services, public relations, and 
corporate communications teams, as well as the company’s office of 
public policy in Washington, DC. Prior to VHA, Mr. Regier served 
since September 1995 as Senior Vice President, General Counsel, 
Secretary, and Corporate Responsibility Officer for the Seton 
Healthcare Network, now Seton Healthcare Family in Austin, 
Texas, where he was responsible for legal and corporate governance 
matters as well as the compliance program. He also has been in 
practice in Chicago, Illinois, prior to that since 1985.
 To his right is Mr. Dick Cowart. Mr. Cowart is a recognized 
authority in advising senior management regarding policy, 
regulatory, and business issues relating to healthcare. He serves as 
strategic counsel to healthcare companies, both for-profit and non-
profit, and counsels providers on business, policy, and governance 
issues, with an emphasis on business transactions. You might have 
seen him – he is nationally known speaker and writer on healthcare 
issues and is the national columnist for Medical News Inc. for 18 
years and is our own local health business columnist for the 
Tennessean for more than 10 years. Mr. Cowart graduated Magna 
Cum Laude from the University of Southern Mississippi with his 
BSBA and with Honors from the University of Mississippi School 
of Law. 
 And our final panelist, to the far right, is Mr. Darin Gordon. 
He is the former Director of Tennessee’s Medicaid program, 
TennCare, with 20 years of experience in public health finance, 
policy, and operations. He has served both Democratic and 
Republican governors and had been in healthcare policy and 
innovation nationally, through consultations with over 35 states. Mr. 
Gordon is a fellow of the Medical Leadership Institute, and a 
member of the Inaugural class of the Nashville Healthcare Council 
fellows program, and board member of Leadership Healthcare. Mr. 
Gordon is a member of the Cressey & Company Distinguished 
Executives Council and a Director of Addus Homecare, Unified 
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Care Group, and Siloam Health. He also serves as Chairman of 180 
Health Partners and is an advisor for myNexus. He is President and 
CEO of Gordon and Associates, LLC.  
 So, thank you for coming. 
 As we get started, one of the things that I wanted to talk 
about first is, it seems relatively certain that at least some parts, or 
potentially all (it’s not totally clear at this point), but some parts of 
the ACA1 will be repealed. And there are various proposals for 
different replacement plans that have been discussed. And one of 
those proposals is the idea of changing Medicaid from its current 
structure into a “block grant” program. So can you describe—Mr. 
Gordon, I don’t know if you are the best one to take this one given 
your history—but tell the audience a bit about what “block grant” 
programs are, what that would mean for the TennCare program and 
other Medicaid programs, and just some general information about 
“block grant” programs and how Tennessee would potentially 
prioritize needy populations under that.
Mr. Gordon: Sure. First, thanks for having me, I really appreciate 
it. Obviously, everywhere I go, the topic comes up pretty regularly. 
But, before I describe block grants, it might be helpful to orient 
people to kind of the current state of financing in Medicaid. Think 
about it in two parts: there are two investors in Medicaid—the state 
and the federal government. The primary investor is the federal 
government; they really put more into the equation. In essence, it is 
an open-entitlement program from the federal perspective. If a 
person is eligible for the program, or they need services that are 
covered under Medicaid, the federal government will put forth the 
funds needed to reimburse the state for their share of the cost of 
those services. However, on the state side, while they still have 
bought into this open entitlement concept, they are limited by the 
amount of state appropriation that they can contribute to this 
equation. So, it’s not as if money can keep going to Medicaid no 
matter what as I think some of the articles out there imply today. It 
comes that way from the federal government, free flowing and no 
cap, but it still requires states to come up with their share of the 
funding. I remember talking to different finance commissioners over 
the years, and when they come in and try to figure out Medicaid and 
seeing that’s the largest budget item, they would ask me “so how 
much total money can we get?” And I would respond, “as much state 
dollars as we can come up with to match it.” But they would always 
respond, “there has got to be a limit,” but there is no limit. And they 
																																								 																				
142. U.S.C. § 18001 et seq. (West 2017). 
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are baffled by this. I mean, literally, they would have to ask me this 
question over and over to get past it. But accepting federal dollars is 
always a challenge for states; and it creates a bit of friction because 
the states are constantly needing to make changes to these very large 
programs due to state dollar limitations, but the federal government 
limits states’ flexibility to change these programs to live within the 
available state funds. 
 Okay, so, think about the block grant concept now. If there 
is a “one size fits all” on block grants is being contemplated, this 
will cause folks to be scared and worried—I tell people “I’m not 
scared of the concept of a block grant.” I am, however, concerned 
over the details of a block grant. The idea being that, instead of the 
feds saying “regardless of how many people you have, or how many 
services are needed, I’m going to send you a set amount of money, 
the concept would be that “I’m going to send you some fixed amount 
of money from which to work with.” Now, is that less than what you 
got the year before? Is it what you go the year before but trended at 
a slower trend rate? All those things matter. States can work within 
this, if designed well. I can tell you, I can design a block grant 
scenario that is something that I would be quite comfortable with. 
But, we don’t know if that’s ultimately going to be the case. 
Depending on how this comes through Congress, it could be more 
of a “function with 90% less money than you had the year before” 
approach. Then, that begs the question, “what types of changes am 
I allowed to make in order to live within that?” So, funding and 
flexibility are hand in hand in this equation. You can’t answer only 
half of the equation. Like “we are going to give you this flexibility” 
– “Well that’s great, so tell me what the financing is going to look 
like.” And vice-versa. They are inextricably linked. The debate is on 
what it’s going to look like. We will see. Is it a dramatic change? 
Yes. That is probably why you’re hearing about this as regularly as 
you are. Because it’s fundamental to the program and how it has 
been run for the last 50 years. It is worth pointing out that, block 
grants are not new. The concept of block grants in Medicaid actually 
was voted on in the Senate and the House under Clinton and 
ultimately passed in both houses under Clinton but ultimately was 
not signed into law by the President. So it is not a new concept. But, 
I think that people feel, more than any other time in our history, that 
we are likely to see some significant change in the financing of 
Medicaid. In order to, one, constrain the growth, and two, give more 
flexibility to the states to manage available funds.  
Mr. Cowart: If I might add just two quick points. First, the CMS 
administrator, Seema Verma, is not yet confirmed, and she is a good 
friend of Darin Gordon and Vice President Pence.  In Indiana, they 
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had operated under a very broad waiver, so the idea that there would 
be a lot more flexibility is safe to say.  Secondly, you may recall that 
the Sebelius2 decision was really the first United States Supreme 
Court decision on the Affordable Care Act3. They stated that the 
federal government couldn’t cram down the Medicaid expansion on 
the states. So I think that while there will be more flexibility, I think 
there will not be a cram down—I think the states will be given 
options. And depending on if your trend rate is up or your trend rate 
is down, and what your benefit package is, states will be able to 
design their flexibility.
Professor Farringer: That leads me to one question – or actually, 
go ahead. 
Mr. Regier: Well, I was only going to say the only other caveat, is 
that’s probably the first thing that the Republican majority will go 
after. And we can say to keep your eye on at a very high level, two 
things: the flexibility afforded to Executive Director and Chief 
Medical Officer of the State Medicaid plans; and then “where is the 
baseline set?” I think states, like Tennessee, that have been very, 
very efficient in managing their Medicaid plans (some might say 
stingy) and have had a 1.5% annual growth could be disadvantaged 
versus states like the state of New York, who have been 
experiencing 12 to 14% of year over year of growth, and also how 
that’s will impact states with an 1115 waiver. That of course 
includes Tennessee, which was the first state in the nation to go to a 
fully managed care plan approach starting in 1994. 
Professor Farringer: That leads nicely into my segue – do you 
think that states will be provided funding under block grants based 
on existing population or based on the amount of money they have 
been given in the past; so, are states that did not expand going to be 
negatively affected by the lack expansion?
Mr. Gordon: I would tell you, amongst the states, and some folks 
at the federal level, there are people who are trying to sort through 
this. The questions that they raise are “Are we at a disadvantage for 
not having expanded?” Similar to what was just said, the concept’s 
specifics are not “out there.” It’s not a concept that makes me run 
and hide. But all those details have to be thought through. And there 
seems to be a push to hurry up and get something out there. I would 
say, since everyone has agreed that there is going to be a 
replacement at the same time a repeal is imposed—we aren’t going 
to have an immediate crisis here. I would just encourage everyone 
																																								 																				
2 Nat’l Fed’n of Indep. Bus. v. Sebelius, 567 U.S. 519 (2012). 
3 See generally 42. U.S.C. § 18001 et seq.  
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working on this to be thoughtful, if there is ever a time to take 
something slow, 18% of GDP is something that we should REALLY 
take our time on to get it right. Make sure that you go through all 
these different levels of questions and make sure that you don’t set 
up a system with perverse incentives.  
Professor Farringer: Okay, so, that leads me to another question, 
sort of about the idea of repeal and replace. Most of what we talk 
about—most of what we hear about—is the pieces that need to be 
repealed. We don’t hear a lot about the quality improvement and the 
quality-centered programs and a lot of the pilot programs that were 
enacted in connection with the ACA.4 So, what do you think is going 
to happen to some of those sorts of programs5 and pilot programs 
and reimbursement explorations that have been going on as part of 
the ACA, that really have nothing to do with insurance, nothing to 
do with the individual mandate, and not, I would say, the kind of 
hot-button issues that are causing the repeal discussion?
Mr. Regier: You are talking about, I think, the perfect storm 
scenario for hospitals. One thing that I would point out is the quality-
based programs that are built into the ACA6 really didn’t start–these 
didn’t originate with President Obama. President Bush and former 
Health & Human Services Secretary Leavitt, had actually started the 
pay-for-performance quality-based system well before President 
Obama was elected into office. So these were Republican ideas that 
were wrapped into the ACA to appeal to those on the “R” side of the 
aisle, to try gain some political support for that statute. You know, 
as part of the “three-legged stool” of insurance reforms: increasing 
access to coverage, and improving quality while lowering costs—
the three broad components of the ACA. I don’t expect the quality 
initiatives to go away—they generally are saving money for the 
federal government. Which is—when the policy perspective is “we 
aren’t getting what we are paying for in healthcare” –which IS the 
policy perspective on the federal level, I don’t expect this will go 
away. A risk for providers, though, is that as pay-for-performance is 
forcing down Medicare reimbursement (which for a typical hospital 
provider is 40% to 45%, even so much as 50%), some institutions, 
at the same time, will lose the Medicaid expansion, which means we 
																																								 																				
4 42 U.S.C. § 1395b-1 (West 2017); see e.g., Ctrs. for Medicare & Medicaid Servs., 
Linking Quality to Payment, available 
athttps://www.medicare.gov/hospitalcompare/linking-quality-to-payment.html (last 
visited Nov. 1, 2017). 
5 See e.g., Melinda K. Abrams et al., The Affordable Care Act’s Payment and Delivery 
System Reforms: A Progress Report at Five Years, THE COMMONWEALTH FUND (May 7, 
2015) http://www.commonwealthfund.org/publications/issue-briefs/2015/may/aca-
payment-and-delivery-system-reforms-at-5-years. 
6 42 U.S.C. § 1395b-1;	42 U.S.C. §§ 299b –31, 300kk, & 3299b.  
7 INDUSTRIES PERSPECTIVES ON HEALTHCARE  VOL. 1 
	
will not have people getting Medicaid coverage; we will lose the 
mandate, and we are definitely going to lose the tax credits and tax 
subsidies provided under the ACA7, which will affect individuals’ 
ability to buy insurance coverage. So I think there may be something 
to replace that, but it is likely that there will be fewer people with 
insurance—so more uncompensated care. And, we still have the 
reductions in disproportionate share funding because that was part 
of the bargain about expanding coverage. We will reduce the—there 
is a payment stream called the disproportionate share hospital 
funding which is made available by the federal government to those 
providers that provide a very high degree of care to the Medicaid 
population—which is, I think, admittedly outside the beltway to be 
reimbursed. That, I don’t think, will come back, because the fiscal 
pressure is too great, and so you are going to have continued 
pressure on providers by way of lower reimbursement, higher 
quality expectations, fewer people with insurance, and fewer dollars 
coming from the federal government to help offset that cost. It’s a 
dream world. 
Mr. Cowart: First off, Repeal and Replace—I think we will talk 
about that separately. On quality, I think the two big pieces of 
bipartisan legislation were MACRA8 and Healthy Cures9, both of 
which passed the House and Senate with supermajorities. So, I think 
those are pretty solid. However, we have an HHS Secretary who is 
a general orthopedic surgeon.10 If you were to ask him if we should 
design quality regulations in Washington, he would tell you that’s 
nice but physicians decide quality not Washington bureaucrats. 
Regarding competition, if we are ever going to have true price 
competition we’ve got to have common prices, and we’ve got to 
have some degree of transparency. What people are buying and what 
does it cost. The process works best when the government can set 
some parameters. Frame the marketplace, and then withdraw and 
allow the marketplace to do its thing. I think there is a lot of interest 
in creating a marketplace, creating transparency, getting pricing and 
quality data into the marketplace but not trying to regulate it from 
Washington. And I think you are going to see some interesting 
things that we have in Tennessee. Now, I think, one of the more 
interesting things is what the state put in its state employee health 
plan request for proposal. It included a section on bundled payments 
to cover all the state employee healthcare insurance. Whoever won 
																																								 																				
742 U.S.C. § 18082. Ctrs. for Medicare and Medicaid Servs., Premium Tax Credit, 
HEALTHCARE.GOV, https://www.healthcare.gov/glossary/premium-tax-credit/ (last visited 
Nov. 1, 2017). 
8 Medicare Access and CHIP Reauthorization Act of 2015, Pub. L. No. 114–10, 129 Stat. 
87 (2015). 
9 21st Century Cures Act, Pub. L. No. 114-255, 130 Stat. 1033 (2016). 
10 Secretary of Health and Human Services at the time of publication was Tom Price.  
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that contract had to create pricing for 75 of these highest use 
procedures—essentially creating a pricing framework that could be 
used as marketplace price and transparency. The State was 
attempting to use its purchasing power to create a marketplace but 
not necessarily regulate that marketplace. 
Mr. Gordon: Dr. Price, the future secretary of HHS, said a lot of 
things early on11 that caused me to be concerned for the future of the 
Center of Medicare and Medicaid Innovation12 but also about value 
based purchasing in general. Even before being considered for the 
Secretary of HHS, while he was with the Georgia Medical 
Association, he made comments regarding concerns over the move 
to value based purchasing.13 However, at his confirmation hearing a 
few days ago, he actually said he could see how the Center could be 
repurposed and used to promote innovations at the state level and 
how the move to value is the new direction things are moving 
towards. He said “I could see some value with continuing CMMI 
with a different focus” but he didn’t really go into a lot of detail. To 
some degree it made me feel “will the priorities be the same?” 
Probably not. May there be some different things they invest in? 
Probably. Dick is right, the degree of control of those programs 
might be lessened and allow things to flow more naturally from the 
states. But the idea of value first is one of the biggest components 
of all that. With Tennessee being a leader of the country on the move 
from volume to value, this is important. If you look at Arkansas or 
Ohio, you see other states stepping out as well and doing similar 
things to Tennessee and trying to move things forward. Medicare 
has been sampling a lot of value based models, but the states have 
been sampling a lot of value based models as well. So the move to 
value isn't just being driven from within the beltway. So, even if they 
change some direction at the federal level on this topic, states will 
continue to push forward. In fact, I said whenever we applied for a 
grant to help implement value based purchasing that, I wish we 
hadn’t applied for the grant because we could have moved faster 
without it than with the grant. So the interest to move from volume 
has always been driven by the states because, like has been stated, it 
																																								 																				
11 Linda Qiu, Schumer: Trump and his HHS Pick Tom Price at Odds on Medicare, 
POLITIFACT (Jan. 10, 2017, 1:58 PM) http://www.politifact.com/truth-o-
meter/statements/2017/jan/10/charles-schumer/schumer-trump-and-his-hhs-pick-tom-
price-odds-medi/. 
12 42 U.S.C. § 1315a.	
13See Bruce Japsen, As Trump’s HHS Secretary, Tom Price Could Slow Shift to Value-
Based Care, FORBES (Nov. 29, 2016, 7:02 AM) 
https://www.forbes.com/sites/brucejapsen/2016/11/29/as-trumps-hhs-secretary-tom-
price-could-slow-shift-to-value-based-care/#5f8ec250636f; see also Shannon Muchmore, 
As HHS Secretary, Price Would Likely Focus on State Healthcare Reform, MODERN 
HEALTHCARE (Nov. 22, 2016),	
http://www.modernhealthcare.com/article/20161122/NEWS/161129971.  
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is a building block to a more functioning market. In and of itself, it 
isn’t going to make a functioning market, although it is a critical 
tool. Once you get to a point of understanding what all is 
encompassed in a particular procedure—from start to finish—then 
you are better able to help people understand what all they would be 
purchasing and how to compare, apples to apples, both quality and 
cost. So, I don’t see that movement stopping. Dr. Price’s more recent 
comments are encouraging to a lot of folks. It gives comfort that, in 
some form or fashion, there will continue to be a focus and funding 
to support greater innovation. 
 To your point, I think we do see a lot of uncertainty, not just 
with providers but also the investment community. There are a lot 
of folks holding back to wait and see where things are headed. If 
anyone is out there right now trying to get providers to sign a new 
agreement with them related to some grant they received, I would 
probably think they are going to have a hard time convincing the 
provider to change processes and change their systems to 
accommodate that right now. So I think the broader system is 
pausing, or at least has slowed down, for the moment until we see 
more details on what is likely to come. And when those details are 
available, things will gear back up and we will begin to see changes 
accelerate once again. 
Professor Farringer: Do you think that is true for accountable 
care organizations (ACOs)? 
Mr. Gordon: I do think that is true for some ACOs. It depends on 
where or how they originated. Some ACOs came directly out of 
grant funding from Medicare. Others originated more organically–
driven by local market dynamics. Some ACOs were born out of a 
change in the healthcare world more generally. But if, let’s say, 
Medicare suddenly does back out, of participating in ACOs, then the 
ACOs are going to be hard-pressed to make it work. Could they 
continue? Yes. The big question would be what would be 
everyone’s purchasing situation? If I as a payer go to Vanderbilt and 
I say I am going to do  an ACO arrangement  this way and another 
person says they will do it a different way, and another says they 
will do it yet  another way, you are setting Vanderbilt, and the 
model, up for failure. So, if any one of those large payers back out, 
then an ACO is going to struggle to bet a viable option. And I don’t 
think we know enough at this point. 
Mr. Cowart: I think it is important to understand that in the 50+ 
years we have had Medicare, it was principally a fee for service 
programs; Part A for hospitals and Part B for doctors and 
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outpatients. In the early 90s, Part C, Medicare Advantage is created, 
and then Medicare Part D under President Bush for pharmacy 
benefits.  You had essentially two models at both ends of the 
spectrum - fee for service and capitation. What is in the middle is a 
shared savings program. Medicare’s version of that is called an 
Accountable Care Organization.  And there is a lot in the private 
sector also private payers. So, I think there is going to be a lot of 
activity in the shared savings space—that is not limited only to 
Medicare ACOs. 
Professor Farringer: It will just be how we all coalesce. 
Mr. Regier: Well, I mean the clear impetus is to say to the provider 
community, (from the payer’s side), “we expect you to be prepared 
to accept financial and operating risks for a population of our 
enrollees for a period of time, and for all the services they need from 
the beginning of life to the end of life.” So, there is flexibility in how 
you do that. Like, how you structure that kind of a model. We have 
taken the approach today to try to assemble an affiliated network, on 
the theory that you cannot afford to own everything. An affiliated 
network, to one day be in the position to be able to accept that degree 
of risk for a population, is difficult. So that is one way that you can 
try to position yourself to be like an ACO at that level.  
Mr. Gordon: One last point on that…any of those payment or 
quality initiatives that we have talked about in this conversation, 
require some degree of alignment. States are out there and they are 
trying out new things and so are the private payers, they are out 
front. And everyone is concerned what Medicare is going to do. All 
the efforts over the last 5 years since the states were investing in this 
could all be for nothing if Medicare goes in a completely different 
direction. If they go in another direction it can shift the entire 
system. So that is something that everyone is going to want to watch. 
Not so much “will an ACO develop?” I think the elements and the 
principles behind those are fine. I think that the principles will still 
be there. I think the question will be “will Medicare come out with 
a direction or will they let it be something that everyone else 
drives?”
Professor Farringer: Okay! So, one other thing that has been talked 
about, I think it was talked about in the debates leading up to the 
Presidential election and significantly since the election, is the idea 
that we would include in any replacement plan the ability of people 
to purchase insurance across state lines. So, maybe talk about that a 
little bit to the audience and tell us some of the pros and cons of the 
approach and why its proponents say it would ultimately reduce 
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healthcare spending. And then any legal concerns that might come 
up with that – especially I think on the insurance side from the state’s 
perspective. States all have their own insurance laws that are driven 
towards protecting their residents, related to making sure that their 
residents and insurers of the state are not doing things that are hurtful 
to their own residents. So, what are some of the legal implications 
for states as we think through this?
Mr. Cowart: Sure. We might need a primer on Repeal and Replace 
before we do a primer on insurance. Repeal and Replace is a 
campaign term. We are not going to replace the Affordable Care Act 
without 60 Republican senators. And you may recall six years ago 
when Scott Brown won the election in Massachusetts, there were 
only 59 Democrat Senators. Because they attempted to cram through 
the Affordable Care Act, there are many technical errors. And they 
ultimately had to pass it through using budget reconciliation. For 
those law students who are here, the House represents the passion of 
the People. They pass things pretty much on party lines. The Senate 
is supposed to be the waiting pot for deliberation, so it takes 60 votes 
to suspend debate, or cloture. It is not 60 votes to pass. So that’s why 
that magic number is 60; otherwise you have filibusters. Now one 
of the things that is exempt from cloture is the federal budget. The 
nation needs to have an annual budget. So it only requires a majority. 
And by the way, since we are watching it on TV every morning, the 
Democrats decided that every confirmation, except the United 
States Supreme Court, is exempt from cloture. The nominees are all 
going to be confirmed unless there is some crime in their 
background. On Repeal and Replace, it is largely going to be budget-
driven because of reconciliation—it’s got to be. It’s going to take 
away the individual mandate,14 take away the employer mandates,15 
and the Cadillac tax,16 and take away the medical device tax,17 all of 
which produces the money to fund everything. Without new taxes 
you can’t do much because you don’t have any money. So the 
reformers have got to say “what can we do that doesn’t require new 
taxes?” Because also we want to pass tax reform. All that is kind of 
a stage. You have to understand that you have to fill the vacuum 
																																								 																				
14 26 U.S.C. § 5000A (West 2017); see also78 FED. REG. 78256-01 (Dec. 26, 2013) (to be 
codified at 26 C.F.R. at pts. 1 and 602); See e.g., Ctrs. for Medicare and Medicare Servs., 
The Fee for Not Having Health Insurance, HEALTHCARE.GOV, 
https://www.healthcare.gov/fees/fee-for-not-being-covered/ (last visited Nov. 1, 2017). 
15 26 U.S.C. § 4980H; see also Internal Rev. Serv., Questions and Answers on Employer 
Shared Responsibility Provisions Under the Affordable Care Act, U.S. Dep’t of Treasury, 
https://www.irs.gov/affordable-care-act/employers/questions-and-answers-on-employer-
shared-responsibility-provisions-under-the-affordable-care-act (last visited Nov. 1, 2017). 
16 26 U.S.C. § 4980I. 
17 Internal Rev. Serv., Medical Devise Excise Tax, U.S. Dep’t of Treasury, 
https://www.irs.gov/newsroom/medical-device-excise-tax-frequently-asked-questions 
(last visited Nov. 1, 2017). 
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with something.  If you want to know the founding of Repeal and 
Replace principles, there was a Blair House summit18 with five 
leading Democrats and five leading Republicans, go to the CSPAN 
in the archives, find the Republican plan of the summit, and those 
are the building blocks.19 One of those building blocks is insurance 
across state lines.  Insurance across state lines is really likely. When 
we look at auto insurance, costs are down. It is a lot less expensive 
than it used to be because it is a highly competitive model. For auto 
insurance, there are all kinds of coverage packages. The Affordable 
Care Act20 has a standard national benefit package. We mustn’t 
change that.  We must also end up with more catastrophic coverage. 
The process thus far is whoever can provide the cheapest price gets 
the business. People buy on price, not on benefits. Unless they are 
really sick, and then, if you are an insurer, you don’t want them to 
buy anything. The other thing is, we never federalized any insurance 
regulation. Property, casualty, and life insurance, since the early 
1900s, has been regulated by the states. The whole concern of the 
state insurance commissioners has been to try and regulate this in 
some way. It has them scared—I mean really scared. And 
particularly in states like Tennessee where the insurance 
commissioner doesn’t have a lot of statutory authority.
Professor Farringer: Read between the lines! I was going to ask 
you about that. Do you think it is too difficult?
Mr. Gordon: I think it is going to happen. I think it will pass. I think 
you will see that. I think where it will fall is less clear. I think all our 
crystal balls are out of order. I think it will pass, the question will 
be, is it realistic? And also, how will it play out? Each state’s 
commissioner of insurance has developed a set of regulatory 
guidelines and regulatory frameworks. For them to say that their 
own standards are not good standards would be unusual. To have 
someone come into your state and not abide by those standards, is 
probably going to be problematic. An Insurance commissioner 
would likely be a little concerned about that. But I also think about 
it from a market perspective because in some cases it is not because 
of the regulatory framework that a plan isn't going into a market. 
Even if you change the regulatory criteria, they will still have to 
																																								 																				
18 White House Health Care Summit, Part 1, C-SPAN (Feb. 25, 2010) https://www.c-
span.org/video/?292260-1/white-house-health-care-summit-part-1; see also Kristi Keck, 
John Helton and David DeSola, Highlights from Obama’s Health Care Summit, CNN 
POLITICS (Feb. 25, 2010 9:12 PM) 
http://www.cnn.com/2010/POLITICS/02/25/health.care.summit.updates/index.html.	
19Noam N. Levey and Kyle Kim, A Side-by-Side Comparison of Obamacare and the 
GOP’s replacement plans, L. A. TIMES (July 13, 2017). 
20 42 U.S.C.  § 18022.  
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make a business decision on how likely they could be successful in 
penetrating that market. If it is just not something that they think 
they can do successfully, regardless of the regulatory environment, 
then they just won't do it. If you think about what is involved when 
you take my insurance product and move from Tennessee to 
Alabama, then that insurance company has to maintain a presence 
there and establish provider networks there to support mer. We will 
just have to see how that plays out. There will be a long run-away 
before we see it play out and get a better sense of the practical 
implications of that. 
Mr. Gordon: I like the theory of it, I am just stumbling over the 
details of how you are actually going to make this work. Are you 
going to have a federally mandated set of minimum benefits that 
must be offered as a condition of federal law? And then, how 
transparent is that going to be to a consumer? If the approach is that 
there would be some set of standard disclosure requirements, and 
consumers could at least look at some standard format to say “this 
is clearly what is covered, this is what I’m getting,” that kind of 
conversation might be helpful to a consumer trying to compare their 
options. How you have that for 50 states, which already have an 
established framework, is going to require a long time to create and 
implement. It will take a long, long time. And I suspect that there 
will be many theories on how that will and ought to be done. There 
are some folks that are very aggressive and there are other states that 
are not as aggressive from a regulatory perspective, and so how does 
that all play out?
Professor Farringer: Okay, let’s jump a little bit into…Dick, you 
alluded to one of the biggest things that has been mentioned—the 
removal of the individual mandate, which is the removal of the 
requirement that all purchase insurance, either under an exchange or 
through their employer. So, there has not been a lot of talk of the 
other two pegs of that equation, which are subsidies and credits 
provided to individuals that cannot afford insurance, and then also 
the fact that right now insurers cannot deny insurance to those 
individuals with preexisting conditions. So, talk to me about the 
individual mandate. And if the administration says that we are not 
going to enforce it or if that is the only piece that changes, what is 
the implication? What do insurers think about that? What do 
providers think about that? What are the implications? 
Mr. Cowart: At least politically, Congress has to keep the no 
preexisting condition provision21 and they have to keep the children, 
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up to age 26,22 on the parent’s policy provision—those are key. But 
again, what Congress does next is dependent on how much money 
is available and whether they reconcile tax cuts while removing (the 
“repeal” part is removing that tax part) the tax credits. At the end of 
the day you have “x” amount of dollars. It is not nearly the same 
amount of money that Congress had under the Affordable Care Act. 
I think that these will be tax credits. There is some discussion about 
making it catastrophic coverage credit, so making it kind of a 
chronic disease super fund that is administrated at the state levels. 
To say that these are available in a catastrophe, the government’s 
role in funding this and the citizen’s role in funding primary care. 
So I believe that there will not be an individual mandate. There is 
probably going to be an employer mandate. That is just an anathema 
to this administration. 
Mr. Regier: I am going to say this, part of the deal from the hospital 
industry’s perspective, part of the deal was “we are going to get an 
coverage expansion and so we hospitals are going to suck it up and 
take reductions in Medicare payments and in disproportionate share 
funding.” So that deal, now appears to be going away. I am very 
concerned just as a public health matter at the number of people who 
will no longer have insurance. I have heard too many people still 
saying “repeal and restore.” A number of folks are saying “we are 
getting rid of this horrible bill and we are going to restore choice”—
well, choice was no insurance for 47 million people in this country. 
That was not a choice and that is not acceptable. So that, I think, is 
going to be a very big priority for the provider side. And I am 
encouraged because the President has said that it is going to be huge, 
it is going to be great, and it is going to be wonderful. And, at 
Vanderbilt, I would say that we are ready to sit down and talk with 
anybody at any time and at any place to collaborate on a plan to 
increase access to coverage for people in Tennessee and the 
surrounding states.  
Professor Farringer: What about insurers?
Mr. Gordon: Providers and insurers actually are in agreement on 
the idea of broadly based coverage, for a variety of reasons. Really, 
on the insurance side, the whole idea behind the mandate was to 
balance out the risk pools. States that have expanded to 138% of the 
poverty level, took on some of the risk for those that were 100-138% 
of poverty that would have otherwise been incurred in the individual 
market in those states and that may have moderated the risk in those 
																																								 																				
22 29 C.F.R. § 2590.715-2714 (2017); Ctrs. for Medicare and Medicaid Servs., Premium 
Tax Credit, HEALTHCARE.GOV, https://www.healthcare.gov/young-adults/children-under-
26 (last visited Nov. 1, 2017). 
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markets, but even so, there were still problems. Risk adjustments, 
risk corridors and reinsurance would have helped stabilize the 
market as well but these common actuarial tools ended up getting 
caught in the political world and were not fully leveraged. If you use 
these actuarial levers that are common to stabilize a volatile market, 
you help to balance out some of the issues. We would not have seen 
the degree of issues that seem to have played out across the country 
if those tools could have been more fully used. I say all that but the 
individual mandate was also supposed to be a way to try to balance 
out all that, but it didn't work. There is a lot of interconnectedness. 
Does that mean you cannot do things? No. It just means you have to 
understand how all these things fit together. I, personally, was not 
convinced that the way that the individual mandate was structured, 
that it, had enough of an effect that people were looking for and 
hoped for. So, that one component, and I haven’t seen information 
out there that says “those that got insured, that the mandate was the 
biggest driver or if it was the subsidies?” So the question is what 
works most effectively? A lot would argue, it goes back to Dick’s 
point, people are very price sensitive. When you look at the 
penalties, I mean, I had people reach out to me saying “I did the 
math, I want a non-ACA plan, it is significantly less costly than an 
ACA compliant plan.” 23 But I would say, in looking at the entire 
system, you have to recognize that price matters.
Mr. Cowart: Michael mentioned one phrase I want to—one of the 
big wild cards—“Repeal and Restore.” The “Restore” piece depends 
on provider unity. If you are in the South, you needed to expand 
Medicaid to get whole. There are many moving parts. If we are 
going to end up with an auto insurance model, providers may close 
ranks and say “Restore my Medicare cuts.” Restore my Medicare 
payments and I’ll deal with that. And it would not be a bad judgment 
call for a provider.  If you restore these healthcare cuts and you 
eliminate the taxes, there is no money to fund anything. That is why 
you end up with these local options—because there is no money 
except for a few tax credits. 
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https://healthchoiceone.com/what-does-aca-compliant-mean/ (last visited Nov. 1, 2017). 
